These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36318270)

  • 1. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals.
    Saida K; Maroofian R; Sengoku T; Mitani T; Pagnamenta AT; Marafi D; Zaki MS; O'Brien TJ; Karimiani EG; Kaiyrzhanov R; Takizawa M; Ohori S; Leong HY; Akay G; Galehdari H; Zamani M; Romy R; Carroll CJ; Toosi MB; Ashrafzadeh F; Imannezhad S; Malek H; Ahangari N; Tomoum H; Gowda VK; Srinivasan VM; Murphy D; Dominik N; Elbendary HM; Rafat K; Yilmaz S; Kanmaz S; Serin M; Krishnakumar D; Gardham A; Maw A; Rao TS; Alsubhi S; Srour M; Buhas D; Jewett T; Goldberg RE; Shamseldin H; Frengen E; Misceo D; Strømme P; Magliocco Ceroni JR; Kim CA; Yesil G; Sengenc E; Guler S; Hull M; Parnes M; Aktas D; Anlar B; Bayram Y; Pehlivan D; Posey JE; Alavi S; Madani Manshadi SA; Alzaidan H; Al-Owain M; Alabdi L; Abdulwahab F; Sekiguchi F; Hamanaka K; Fujita A; Uchiyama Y; Mizuguchi T; Miyatake S; Miyake N; Elshafie RM; Salayev K; Guliyeva U; Alkuraya FS; Gleeson JG; Monaghan KG; Langley KG; Yang H; Motavaf M; Safari S; Alipour M; Ogata K; Brown AEX; Lupski JR; Houlden H; Matsumoto N
    Genet Med; 2023 Jan; 25(1):90-102. PubMed ID: 36318270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the
    Zhai H; Zheng Y; He Y; Zhang Y; Guo Z; Cui W; Sun L
    Int J Neurosci; 2023 May; 133(5):574-577. PubMed ID: 34078222
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain dopamine-serotonin vesicular transport disease and its treatment.
    Rilstone JJ; Alkhater RA; Minassian BA
    N Engl J Med; 2013 Feb; 368(6):543-50. PubMed ID: 23363473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.
    Zai CC; Tiwari AK; Mazzoco M; de Luca V; Müller DJ; Shaikh SA; Lohoff FW; Freeman N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL
    J Psychiatr Res; 2013 Nov; 47(11):1760-5. PubMed ID: 24018103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder.
    Jacobsen JC; Wilson C; Cunningham V; Glamuzina E; Prosser DO; Love DR; Burgess T; Taylor J; Swan B; Hill R; Robertson SP; Snell RG; Lehnert K
    J Inherit Metab Dis; 2016 Mar; 39(2):305-8. PubMed ID: 26497564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling brain dopamine-serotonin vesicular transport disease in
    Young AT; Ly KN; Wilson C; Lehnert K; Snell RG; Reid SJ; Jacobsen JC
    Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing results in identification and treatment of brain dopamine-serotonin vesicular transport disease.
    Rath M; Korenke GC; Najm J; Hoffmann GF; Hagendorff A; Strom TM; Felbor U
    J Neurol Sci; 2017 Aug; 379():296-297. PubMed ID: 28716265
    [No Abstract]   [Full Text] [Related]  

  • 8. Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish.
    Baronio D; Chen YC; Decker AR; Enckell L; Fernández-López B; Semenova S; Puttonen HAJ; Cornell RA; Panula P
    Acta Physiol (Oxf); 2022 Jan; 234(1):e13725. PubMed ID: 34403568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense variant in
    Padmakumar M; Jaeken J; Ramaekers V; Lagae L; Greene D; Thys C; Van Geet C; BioResource N; Stirrups K; Downes K; Turro E; Freson K
    JIMD Rep; 2019 May; 47(1):9-16. PubMed ID: 31240161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
    Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
    Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.
    Lohr KM; Stout KA; Dunn AR; Wang M; Salahpour A; Guillot TS; Miller GW
    ACS Chem Neurosci; 2015 May; 6(5):790-9. PubMed ID: 25746685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2.
    Kaasalainen S; Arikka H; Martikainen MH; Kaasinen V
    Case Rep Neurol Med; 2024; 2024():4767647. PubMed ID: 38716424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motility phenotype in a zebrafish vmat2 mutant.
    Sveinsdóttir HS; Decker A; Christensen C; Lucena PB; Þorsteinsson H; Richert E; Maier VH; Cornell R; Karlsson KÆ
    PLoS One; 2022; 17(1):e0259753. PubMed ID: 34986152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.
    Bernstein AI; Stout KA; Miller GW
    J Neurosci Methods; 2012 Aug; 209(2):357-66. PubMed ID: 22698664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VMAT2 and Parkinson's disease: harnessing the dopamine vesicle.
    Lohr KM; Miller GW
    Expert Rev Neurother; 2014 Oct; 14(10):1115-7. PubMed ID: 25220836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.
    Crowley JJ; Lipsky RH; Lucki I; Berrettini WH
    Psychiatr Genet; 2008 Oct; 18(5):248-51. PubMed ID: 18797399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.
    Glatt CE; Wahner AD; White DJ; Ruiz-Linares A; Ritz B
    Hum Mol Genet; 2006 Jan; 15(2):299-305. PubMed ID: 16339215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic AOPEP Loss-of-Function Variants Cause Progressive Dystonia with Prominent Limb Involvement.
    Zech M; Kumar KR; Reining S; Reunert J; Tchan M; Riley LG; Drew AP; Adam RJ; Berutti R; Biskup S; Derive N; Bakhtiari S; Jin SC; Kruer MC; Bardakjian T; Gonzalez-Alegre P; Keller Sarmiento IJ; Mencacci NE; Lubbe SJ; Kurian MA; Clot F; Méneret A; de Sainte Agathe JM; Fung VSC; Vidailhet M; Baumann M; Marquardt T; Winkelmann J; Boesch S
    Mov Disord; 2022 Jan; 37(1):137-147. PubMed ID: 34596301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
    Ng J; Zhen J; Meyer E; Erreger K; Li Y; Kakar N; Ahmad J; Thiele H; Kubisch C; Rider NL; Morton DH; Strauss KA; Puffenberger EG; D'Agnano D; Anikster Y; Carducci C; Hyland K; Rotstein M; Leuzzi V; Borck G; Reith ME; Kurian MA
    Brain; 2014 Apr; 137(Pt 4):1107-19. PubMed ID: 24613933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.
    Bohlega SA; Abou-Al-Shaar H; AlDakheel A; Alajlan H; Bohlega BS; Meyer BF; Monies D; Cupler EJ; Al-Saif AM
    Parkinsonism Relat Disord; 2019 Jul; 64():145-149. PubMed ID: 30975617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.